Aytu BioPharma (AYTU)
(Delayed Data from NSDQ)
$2.25 USD
+0.01 (0.45%)
Updated Aug 12, 2025 04:00 PM ET
After-Market: $2.27 +0.02 (0.89%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth B Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
09/25/2025
Time: -- |
6/2025 | $-0.02 | 0.00% |
Earnings Summary
For their last quarter, Aytu BioPharma (AYTU) reported earnings of $0.20 per share. This reflects a breakeven earnings surprise. Look out for AYTU's next earnings release expected on September 25, 2025. For the next earning release, we expect the company to report earnings of -$0.02 per share, reflecting a year-over-year increase of 97.56%.
Earnings History
Price & Consensus
AYTU FAQs
Based on past history, Zacks believes Aytu BioPharma Inc. (AYTU) will report their next quarter earnings on September 25, 2025. For the next earning release, we expect the company to report earnings of -0.02 per share, reflecting a year-over-year increase of 97.56.
Based on past history, Zacks believes Aytu BioPharma Inc. (AYTU) will report their previous quarter earnings %%TIME_OF_DAY_CODE%% on September 25, 2025.
The Zacks Consensus Estimate for Aytu BioPharma Inc. (AYTU) for the quarter ending June 2025 is $-0.02 a share. We expect Aytu BioPharma Inc. (AYTU) to report earnings in line with the consensus estimate of $-0.02 per share
In the earnings report for the quarter ending in June 2024, Aytu BioPharma Inc. (AYTU) announced earnings of $-0.82 per share versus the Zacks Consensus Estimate of $ per share, representing a surprise of %.